{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:53:46Z","timestamp":1794750826954,"version":"4.9.1"},"reference-count":10,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":635,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,3,29]]},"abstract":"<jats:p>Twenty\u2010four apparently unrelated Italian patients with autosomal dominant type 1 von Willebrand disease (VWD) and a clear autosomal pattern of inheritance of bleeding symptoms were screened for the C1149R and C1130F mutations. None of the patients had the C1149R mutation; three patients and four affected relatives were heterozygous for the C1130F mutation. The mutation appeared to be linked to a single haplotype, defined by five genetic markers [variable number tandem repeat (VNTR) I and II in intron 40, <jats:italic>Rsa<\/jats:italic>I in exons 13 and 18 and <jats:italic>Hph<\/jats:italic>I in exon 28], suggesting a founder effect. The patients responded well to desmopressin infusion. The C1130F mutation might have a dominant negative effect on the secretion of the normal protein that desmopressin would appear to overcome.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01944.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:23:03Z","timestamp":1047363783000},"page":"876-879","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect"],"prefix":"10.1111","volume":"108","author":[{"given":"Giancarlo","family":"Castaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C. J.","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Missiaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rodeghiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"186a","article-title":"Mechanism of a dominant negative von Willebrand factor mutation: the point mutation C386R results in dominant type 1 von Willebrand disease by causing retention of mutant wild\u2010type heterodimers in the endoplasmic reticulum (ER) (Abstract)","volume":"92","author":"Bod\u00f2 I.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08921.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830490406"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0037-1615050","article-title":"Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin","volume":"79","author":"Eikenboom J.C.J.","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.4.796.796"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00399a013"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199701000-00001"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb08176.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.1.27.27"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01944.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01944.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01944.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:04:31Z","timestamp":1698563071000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01944.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,29]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,3,29]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01944.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01944.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,29]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}